Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants
Quality of Life and Healthcare Utilization Substudy
3 other identifiers
observational
1,224
1 country
67
Brief Summary
The purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2002
Longer than P75 for all trials
67 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2002
CompletedFirst Submitted
Initial submission to the registry
October 6, 2006
CompletedFirst Posted
Study publicly available on registry
October 11, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2008
CompletedApril 21, 2014
April 1, 2014
6.8 years
October 6, 2006
April 16, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Quality of life as assessed by self-administered questionnaires, a symptom severity survey, and an assessment of body appearance
Throughout study
Self-reported healthcare utilization
Throughout study
Recorded medications used by participants
Throughout study
Cost of treating HIV/AIDS
Throughout study
Study Arms (2)
1
Participants following a drug conservation (DC) regimen in which ART was stopped or deferred until CD4 cell count dropped below 250 cells/mm3, initiated until CD4 cell count was at least 350 cells/mm3, and then followed by episodic ART based on CD4 cell count
2
Participants following a viral suppression (VS) regimen in which ART was continued to keep viral loads as low as possible, regardless of CD4 cell count
Interventions
Various antiretroviral therapy combinations already being administered to participants
Eligibility Criteria
Participants using conservation and viral suppression ART treatment regimens
You may qualify if:
- Coenrollment in the SMART study
- Parent or guardian willing to provide informed consent, if applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (67)
UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS
Fresno, California, 93702, United States
Dr. M. Estes Med. Practice CRS
Mill Valley, California, 94941-3013, United States
Dr. Robert Scott Med. Practice CRS
Oakland, California, 94609, United States
East Bay AIDS Ctr. CRS
Oakland, California, 94609, United States
Dr. Shawn Hassler Med. Practice CRS
San Francisco, California, 94102, United States
Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS
San Francisco, California, 94110, United States
Dr. Virginia Cafaro Med. Practice CRS
San Francisco, California, 94114-1010, United States
Dr. William Owen Med. Practice CRS
San Francisco, California, 94114-1010, United States
Castro-Mission Health Ctr. CRS
San Francisco, California, 94114, United States
San Francisco VAMC, Infectious Diseases Clinic CRS
San Francisco, California, 94121, United States
UCSF PHP, Gen. Internal Medicine Practice CRS
San Francisco, California, 94143, United States
Beacon Clinic at Boulder CRS
Boulder, Colorado, 80501-4507, United States
Denver Infectious Diseases Consultants CRS
Denver, Colorado, 80204-4507, United States
Kaiser Permanente of Denver CRS
Denver, Colorado, 80204-4507, United States
Univ. of Colorado Health Science Ctr. CRS
Denver, Colorado, 80204-4507, United States
Denver Public Health CRS
Denver, Colorado, 80204, United States
Eastside Family Health Ctr. CRS
Denver, Colorado, 80205, United States
Denver VAMC CRS
Denver, Colorado, 80220, United States
Denver Public Health CRS - INSIGHT
Denver, Colorado, United States
Western Infectious Disease Consultants CRS
Wheat Ridge, Colorado, 80033, United States
Univ. of Connecticut Health Ctr. CRS
Farmington, Connecticut, 06030, United States
Yale Univ. School of Medicine, NE ProACT - New Haven CRS
New Haven, Connecticut, 06510, United States
Hosp. of St. Raphael CRS
New Haven, Connecticut, 06511, United States
VAMC West Haven CRS
West Haven, Connecticut, 06516, United States
Georgetown Wellness Clinic
Georgetown, Delaware, 19947, United States
Christiana Care Health Services HIV Program CRS
Wilmington, Delaware, 19801, United States
Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS
Washington D.C., District of Columbia, 20422, United States
Miami VAMC CRS
Miami, Florida, 33125, United States
Atlanta VAMC CRS
Decatur, Georgia, 30033, United States
Klein & Slotten Medical Associates CRS
Chicago, Illinois, 60610, United States
Cook County Hosp. CORE Ctr.
Chicago, Illinois, 60612, United States
Univ. of Illinois Family Ctr. for Infectious Disease CRS
Chicago, Illinois, 60612, United States
Univ. of Chicago Hosps. CRS
Chicago, Illinois, 60637, United States
Lakeshore Infectious Disease Associates CRS
Chicago, Illinois, 60657, United States
North Side Family Medicine CRS
Chicago, Illinois, 60657, United States
Northwestern Memorial Physicians Group CRS
Chicago, Illinois, 60657, United States
Earl K. Long Med. Ctr., LSU - Mid City EIC Clinic CRS
Baton Rouge, Louisiana, 70805, United States
James Osterberger, MD (Private Med. Practice) CRS
Baton Rouge, Louisiana, 70808-4390, United States
Med. Ctr. of Louisiana at New Orleans, HIV Outpatient Clinics CRS
New Orleans, Louisiana, 70112, United States
Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
New Orleans, Louisiana, 70112, United States
New Orleans VAMC CRS
New Orleans, Louisiana, 70146, United States
CRI-Boston CRS
Boston, Massachusetts, 02115, United States
CRI-Springfield CRS
Springfield, Massachusetts, 01107, United States
Henry Ford Hosp. CRS
Detroit, Michigan, 48202, United States
Univ. of Mississippi Med. Ctr., Div. of Infectious Diseases CRS
Jackson, Michigan, 39216-4505, United States
Michigan State Univ., Infectious Disease Clinic CRS
Lansing, Michigan, 48910, United States
Mt. Clemens Gen. Hosp. CRS
Mount Clemens, Michigan, 48043, United States
Providence Hosp,-Newland Med. Assoc Inc CRS
Southfield, Michigan, 48075, United States
ID Care Inc. - Hillsborough CRS
Hillsborough, New Jersey, 08844, United States
Cathedral Healthcare System, St. Michael's Med. Ctr. CRS
Newark, New Jersey, 07103, United States
New Jersey Community Research Initiative, Jeffrey Bomser Clinic CRS
Newark, New Jersey, 07103, United States
St. Joseph's Hosp. & Med. Ctr. of New Jersey CRS
Paterson, New Jersey, 07503, United States
Raritan Bay Med. Ctr., Perth Amboy Division CRS
Perth Amboy, New Jersey, 08861, United States
ID Care - Randolph CRS
Randolph Township, New Jersey, 07869, United States
Infectious Disease Specialists of N.J., North Jersey Community Research Initiative CRS
Union, New Jersey, 07083, United States
St. Vincent Hosp. & Med. Ctr. CRS
New York, New York, 10011, United States
Metropolitan Hosp. Ctr. CRS
New York, New York, 10029, United States
Harlem Hospital Ctr./Columbia University CRS (Gordin CTU)
New York, New York, 10037-1802, United States
Harlem Hosp. Ctr., Outpatient Clinics (New York) CRS
New York, New York, 10037, United States
Jacobi Med. Ctr., Ambulatory Care Pavillion CRS
The Bronx, New York, 10461, United States
Legacy Community Health Services, Inc. CRS
Houston, Texas, 77006, United States
Baylor College of Medicine, Thomas St. Clinic CRS
Houston, Texas, 77030, United States
Houston AIDS Research Team CRS
Houston, Texas, 77030, United States
Michael E. DeBakey VAMC CRS
Houston, Texas, 77030, United States
Thomas Street Clinic CRS
Houston, Texas, 77030, United States
Univ. Clinical Research Ctr., Memorial Hermann Hosp. CRS
Houston, Texas, 77030, United States
South Texas Veterans Health Care System, Immunosuppression Clinic CRS
San Antonio, Texas, 78229, United States
Related Publications (4)
Anis AH, Guh D, Hogg RS, Wang XH, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS. The cost effectiveness of antiretroviral regimens for the treatment of HIV/AIDS. Pharmacoeconomics. 2000 Oct;18(4):393-404. doi: 10.2165/00019053-200018040-00007.
PMID: 15344307BACKGROUNDByrne MW, Honig J. Health-related quality of life of HIV-infected children on complex antiretroviral therapy at home. J Assoc Nurses AIDS Care. 2006 Mar-Apr;17(2):27-35. doi: 10.1016/j.jana.2006.01.003.
PMID: 16800165BACKGROUNDLiu C, Ostrow D, Detels R, Hu Z, Johnson L, Kingsley L, Jacobson LP. Impacts of HIV infection and HAART use on quality of life. Qual Life Res. 2006 Aug;15(6):941-9. doi: 10.1007/s11136-005-5913-x.
PMID: 16900275BACKGROUNDLowy A, Page J, Jaccard R, Ledergerber B, Somaini B, Weber R, Szucs T. Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care: a prospective cohort study. AIDS Care. 2005 Aug;17(6):698-710. doi: 10.1080/09540120412331336689.
PMID: 16036256BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Wafaa El-Sadr, MD, MPH
Harlem AIDS Treatment Group, Harlem Hospital Center
- STUDY CHAIR
James Neaton, PhD
CPCRA Statistical and Data Management Center/CCBR
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2006
First Posted
October 11, 2006
Study Start
January 1, 2002
Primary Completion
November 1, 2008
Study Completion
November 1, 2008
Last Updated
April 21, 2014
Record last verified: 2014-04